PSA Today Dec 29: Market finds new energy / Increased focus on ammonia / Sumitomo Dainippon Pharma up on US$4.2bil deal – Nikkei +2.66%
Japan Market Comment by Pelham Smithers and Joel ScheimanNikkei ¥ 27,568.15 (+¥714.12 / + 2.66%); Topix ¥ 1,819.18 (+¥31.14 / + 1.74%); ¥/$103.67
Tags: M3 (2413 JT), ANA (9202 JT), Sony (6758 JT), Nintendo (7974 JT), Japan Tobacco (2914 JT), Canon (7751 JT), Mitsubishi Heavy Industries (7011 JT), Entergy (ETR US), SoftBank Group (9984 JT), Avex (7860 JT), Takashimaya (8233 JT), , J Front Retailing (3086 JT), Minkabu the Infonoid (4436 JT), Sumitomo Dainippon Pharma (4506 JT), Urovant (UROV US), Pfizer (PFE US), Takeda Pharmaceutical (4502 JT), Sumitomo Chemical (4005 JT), Entergy (ETR US)
Main Points
• Market finds new energy
• Increased focus on ammonia
• Sumitomo Dainippon Pharma up on US$4.2bil deal
Founded in 2009, Pelham Smithers Associates (PSA) provides market intelligence on Asian technology, focusing in particular on Japan. The industries covered by our team of specialists are: consumer electronics, telecomms, pharmaceuticals, internet, electronic parts and materials, automotive technology, retail and capital goods.
PSA produces both company and sector reports. The focus of PSA’s research is to identify winners and losers as new technologies impact the top and bottom lines of corporations. Critical to our research is the clear explanation of how these new technologies work and how they impact companies and industries.
The founding partners have worked closely together for twenty years and the team has more than doubled in size since 2012.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.